Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr;29(2):132-8.
doi: 10.7555/JBR.27.20120115. Epub 2012 Dec 20.

Osthole inhibits proliferation of human breast cancer cells by inducing cell cycle arrest and apoptosis

Affiliations

Osthole inhibits proliferation of human breast cancer cells by inducing cell cycle arrest and apoptosis

Lintao Wang et al. J Biomed Res. 2015 Apr.

Abstract

Recent studies have revealed that osthole, an active constituent isolated from the fruit of Cnidium monnieri (L.) Cusson, a traditional Chinese medicine, possesses anticancer activity. However, its effect on breast cancer cells so far has not been elucidated clearly. In the present study, we evaluated the effects of osthole on the proliferation, cell cycle and apoptosis of human breast cancer cells MDA-MB 435. We demonstrated that osthole is effective in inhibiting the proliferation of MDA-MB 435 cells, The mitochondrion-mediated apoptotic pathway was involved in apoptosis induced by osthole, as indicated by activation of caspase-9 and caspase-3 followed by PARP degradation. The mechanism underlying its effect on the induction of G1 phase arrest was due to the up-regulation of p53 and p21 and down-regulation of Cdk2 and cyclin D1 expression. Were observed taken together, these findings suggest that the anticancer efficacy of osthole is mediated via induction of cell cycle arrest and apoptosis in human breast cancer cells and osthole may be a potential chemotherapeutic agent against human breast cancer.

Keywords: apoptosis; breast cancer; cell cycle; osthole; proliferation.

PubMed Disclaimer

Conflict of interest statement

The authors reported no conflict of interest.

Figures

Fig. 1
Fig. 1. Effects of osthole on the proliferation of MDA-MB 435 cells.*P < 0.05, **P < 0.01 vs. control (0 μ mol/L osthole)
Fig. 2
Fig. 2. Effects of osthole on the cell cycle distribution of MDA-MB 435 cells. MDA-MB 435 cells were treated with osthole for 36 hours. Cells were harvested and prepared for the cell cycle detection using flow cytometer as described in the Materials and Methods. Images are shown for one of three separate experiments. A: Control group. B: osthole 25 μmol/L. C: osthole 50 μmol/L. D: osthole 100 μmol/L.
Fig. 3
Fig. 3. Effects of osthole on the apoptosis of MDA-MB 435 cells. MDA-MB 435 cells were treated with osthole (0, 25, 50 and 100 μmol/L) for 36 hours. Cells were harvested and analyzed with annexin V and propidium iodide using flow cytometer as described in the Methods. A: Representative histograms of three separate experiments. B: Results of three separate experiments are shown. Values are expressed as mean±SD. **P < 0.01.
Fig. 4
Fig. 4. Effects of osthole on the expression of p53 and p21 as well as Cdk2 and cyclin D1. MDA-MB 435 cells were treated with osthole (0, 25, 50 and 100 μmol/L) for 36 hours. Cell lysates were immunoblotted with anti-p53 (A) anti-p21 (B) anti-Cdk2 (C) and anti-cyclin D1 (D) antibodies, respectively. β-actin served as loading control.
Fig. 5
Fig. 5. Effects of osthole on the levels of pro-caspase-3, PARP and pro-caspase-9. MDA-MB 435 cells were treated with osthole (0, 25, 50 and 100 μmol/L) for 36 hours. Cell lysates were immunoblotted with anti-pro-caspase-3 (A) anti-PARP (B) and anti-pro-caspase-9 (C) antibodies, respectively. β-actin served as loading control.
Fig. 6
Fig. 6. Effects of osthole on the levels of Bcl-2 (A) and Bax (B). MDA-MB 435 cells were treated with osthole (0, 25, 50 and 100 μmol/L) for 36 hours. Cell lysates were immunoblotted with anti-Bcl-2 and anti-Bax antibodies, respectively. β-actin served as loading control.

Similar articles

Cited by

References

    1. Falandry C, Canney PA, Freyer G, et al. Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer. Ann Oncol. 2009;20(4):615–620. - PubMed
    1. Barnes S. Effect of genistein on in vitro and in vivo model of cancer. J nutr. 1995;125(3 Suppl):777s–783s. - PubMed
    1. Ye L, Gho WM, Chan FL, et al. Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF-7 cells overespressing aromatase. Int J can. 2009;124(5):1028–1036. - PubMed
    1. Wang Y, Lee KW, Chan FL, et al. The red wine polyphenol reseveratrol displays bilevel inhibition on aromatase in breast cancer cells. Toxicol Sci. 2006;92(1):71–77. - PubMed
    1. Seo HS, Ju JH, Jang K, et al. Induction of apoptotic cell death by phytoestrogens by up-regulating the levels of phospho-p53 and p21 in normal and malignant estrogen receptor α-negative breast cells. Nutr Res. 2011;31(2):139–146. - PubMed